Plasma proteomics link menopause timing to brain aging and dementia risk
Wood Alexander, M.; Wood, B.; Oh, H. S.-H.; Bot, V. A.; Borger, J.; Galbiati, F.; Walker, K. A.; Resnick, S. M.; Ochs-Balcom, H. M.; Wyss-Coray, T.; Kooperberg, C.; Reiner, A. P.; Jacobs, E. G.; Rabin, J. S.; Casaletto, K. B.; Saloner, R.
Show abstract
Earlier menopause is a risk factor for several age-related diseases, including dementia. The biological pathways linking menopause timing to later-life brain aging are not understood. Leveraging large-scale plasma proteomics in postmenopausal women from the UK Biobank (N=15,012), earlier menopause was associated with upregulation of pro-inflammatory and extracellular matrix degradation pathways, plus accelerated aging across proteomic clocks of organ and cellular aging, including brain and oligodendrocyte aging. Elevated GDF15, a canonical aging marker, was the top protein correlate of earlier menopause. We observed robust replication of menopause timing proteomic shifts in the Womens Health Initiative Long Life Study (N=1,210). In UKB, proteins associated with earlier menopause, including GDF15, exhibited concordant associations with incident dementia risk and brain atrophy, cerebral small vessel disease burden, and white matter microstructural integrity. Collectively, our findings identify proteomic signatures linking ovarian aging to brain aging, providing a framework to inform interventions to reduce dementia risk.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.